New insights on cell death from radiation exposure
KM Prise, G Schettino, M Folkard, KD Held - The lancet oncology, 2005 - thelancet.com
Ionising radiation has been an important part of cancer treatment for almost a century, being
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
[引用][C] New insights on cell death from radiation exposure
K Prise, G Schettino, M Folkard, K Held - Lancet Oncology, 2005 - pure.qub.ac.uk
New insights on cell death from radiation exposure — Queen's University Belfast Skip to main
navigation Skip to search Skip to main content Queen's University Belfast Home Queen's …
navigation Skip to search Skip to main content Queen's University Belfast Home Queen's …
[引用][C] New insights on cell death from radiation exposure
KM Prise, G Schettino, M Folkard, KD Held - The Lancet Oncology, 2005 - cir.nii.ac.jp
New insights on cell death from radiation exposure | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] New insights on cell death from radiation exposure
KM Prise, G Schettino, M Folkard, KD Held - Lancet Oncol, 2005 - researchgate.net
Radiotherapy is based on the idea that exposure to a sufficient quantity (dose) of ionising
radiation kills or sterilises cells. The first clinical use of radiation for the treatment of tumours …
radiation kills or sterilises cells. The first clinical use of radiation for the treatment of tumours …
New insights on cell death from radiation exposure
KM Prise, G Schettino, M Folkard, KD Held - The Lancet Oncology, 2005 - thelancet.com
Ionising radiation has been an important part of cancer treatment for almost a century, being
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
New insights on cell death from radiation exposure
KM Prise, G Schettino, M Folkard… - The Lancet …, 2005 - pubmed.ncbi.nlm.nih.gov
Ionising radiation has been an important part of cancer treatment for almost a century, being
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
New insights on cell death from radiation exposure
KM Prise, G Schettino, M Folkard, KD Held - The Lancet Oncology, 2005 - infona.pl
Ionising radiation has been an important part of cancer treatment for almost a century, being
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
New insights on cell death from radiation exposure.
KM Prise, G Schettino, M Folkard, KD Held - The Lancet. Oncology, 2005 - europepmc.org
Ionising radiation has been an important part of cancer treatment for almost a century, being
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
New insights on cell death from radiation exposure
KM Prise, G Schettino, M Folkard, KD Held - The Lancet Oncology, 2005 - Elsevier
Ionising radiation has been an important part of cancer treatment for almost a century, being
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At …
[引用][C] New insights on cell death from radiation exposure
KM PRISE - Lancet Oncol., 2005 - cir.nii.ac.jp